Patent Expiry
RIGL: TAVALISSE: recorded patent 8951504 expiry
July 27, 2032 · FOSTAMATINIB DISODIUM. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 27, 2032
- Company
- RIGEL PHARMACEUTICALS INC (RIGL)
- Drug
- FOSTAMATINIB DISODIUM
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
TAVALISSE: recorded patent 8951504 expiry
Orange Book application NDA209299, product 001, listed patent 8951504 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source